Increased levels of galectin-3 were associated with prediabetes and diabetes: New risk factor?

Journal of Endocrinological Investigation

Volumn 38, Issue 5, 2015, Pages 527-533

  Yilmaz, H ^a   Cakmak, M ^a   Inan, O ^b   Darcin, T ^c   Akcay, A ^a  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b Yenimahalle State Hospital   (Turkey)

^c Agrl State Hospital   (Turkey)

Author keywords

Diabetes; Galectin 3; Inflammation; Insulin resistance; Prediabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; GALECTIN 3; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; AUTOANALYZER; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; BLOOD; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN RESISTANCE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; RISK FACTOR;

ADULT; BIOMARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; GALECTIN 3; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS;

EID: 84928667342     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0222-2     Document Type: Article

References (33)

1. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, Larson MG, Levy D (2012) Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 60(14):1249-1256
2. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272(1):55-64
3. van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA (2013) Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 6(2):219-226
4. Djoussé L, Matsumoto C, Petrone A, Weir NL, Tsai MY, Gaziano JM (2013) Plasma galectin 3 and heart failure risk in the Physicians' Health Study. Eur J Heart Fail. doi: 10.1002/ejhf.21
5. Barrow H, Rhodes JM, Yu LG (2013) Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients. Cell Oncol (Dordr) 36(1):9-13
6. Vereecken P, Awada A, Suciu S, Castro G, Morandini R, Litynska A, Lienard D, Ezzedine K, Ghanem G, Heenen M (2009) Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Res 19(5):316-320
7. McCullough PA, Olobatoke A, Vanhecke TE (2011) Galectin-3: a novel blood test for the evaluation and management of patients with heart failure. Rev Cardiovasc Med 12(4):200-210
8. Mensah-Brown EP, Al Rabesi Z, Shahin A, Al Shamsi M, Arsenijevic N, Hsu DK, Liu FT, Lukic ML (2009) Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice. Clin Immunol 130(1):83-88
9. Pang J, Rhodes DH, Pini M, Akasheh RT, Castellanos KJ, Cabay RJ, Cooper D, Perretti M, Fantuzzi G (2013) Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice. PLoS One 8(2):e57915. doi: 10.1371/journal.pone.0057915
10. Pejnovic NN, Pantic JM, Jovanovic IP, Radosavljevic GD, Milovanovic MZ, Nikolic IG, Zdravkovic NS, Djukic AL, Arsenijevic NN, Lukic ML (2013) Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62(6):1932-1944
11. Saksida T, Nikolic I, Vujicic M, Nilsson UJ, Leffler H, Lukic ML, Stojanovic I, Stosic-Grujicic S (2013) Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro. J Cell Physiol 228(7):1568-1576
12. Darrow AL, Shohet RV, Maresh JG (2011) Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3. Physiol Genom 43:1144-1152
13. Karlsen AE, Størling ZM, Sparre T, Larsen MR, Mahmood A, Størling J, Roepstorff P, Wrzesinski K, Larsen PM, Fey S, Nielsen K, Heding P, Ricordi C, Johannesen J, Kristiansen OP, Christensen UB, Kockum I, Luthman H, Nerup J, Pociot F (2006) Immune-mediated beta-cell destruction in vitro and in vivo - a pivotal role for galectin-3. Biochem Biophys Res Commun 344:406-415
14. Pugliese G, Iacobini C, Ricci C, Blasetti Fantauzzi C, Menini S (2014) Galectin-3 in diabetic patients. Clin Chem Lab Med 52(10):1413-1423
15. Weigert J, Neumeier M, Wanninger J, Bauer S, Farkas S, Scherer MN, Schnitzbauer A, Schäffler A, Aslanidis C, Schölmerich J, Buechler C (2010) serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab 95(3):1404-1411
16. Yilmaz H, Celik HT, Ozdemir O, Kalkan D, Namuslu M, Abusoglu S, Atalay CR, Yigitoglu R (2014) Serum galectin-3 levels in women with PCOS. J Endocrinol Invest 37(2):181-187
17. American Diabetes Association (2014) Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl 1):S14-S80
18. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
19. Henderson NC, Sethi T (2009) The regulation of inflammation by galectin-3. Immunol Rev 230(1):160-171
20. ten Oever J, Giamarellos-Bourboulis EJ, van de Veerdonk FL, Stelma FF, Simon A, Janssen M, Johnson M, Pachot A, Kullberg BJ, Joosten LA, Netea MG (2013) Circulating galectin-3 in infections and non-infectious inflammatory diseases. Eur J Clin Microbiol Infect Dis 32(12):1605-1610
21. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-867
22. Dehghan A, Kardys I, de Maat MPM, Uitterlinden AG, Sijbrands EJG, Bootsma AH, Stijnen T, Hofman A, Schram MT, Witteman JCM (2007) Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56:872-878
23. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, Heiss G, Howard BV, Hotamisligil GS, Hu FB, Kuller LH, Manson JE (2007) A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 167:1676-1685
24. Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C (2007) Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30:854-860
25. Lee CC, Adler AI, Sandhu MS, Sharp SJ, Forouhi NG, Erqou S, Luben R, Bingham S, Khaw KT, Wareham NJ (2009) Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 52(6):1040-1047
26. Lee CC, Lorenzo C, Haffner SM, Wagenknecht LE, Festa A, Goodarzi MO, Stefanovski D, Olson NC, Norris JM, Rewers MJ, Hanley AJ (2013) The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetologia 56(1):112-120
27. Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Smith GD, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M (2008) Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5(8):e155. doi: 10.1371/journal.pmed.0050155
28. de Rn P, Peila R, Ding J et al (2006) Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care 29:1902-1908
29. Doi Y, Kiyohara Y, Kubo M et al (2005) Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: the Hisayama Study. Diabetes Care 28:1211-1213
30. Lin J, Zhang M, Song F, Qin J, Wang R, Yao P, Ying C, Hu FB, Liu L (2009) Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population. Diabetes Metab Res Rev 25:219-223
31. Sabanayagam C, Shankar A, Lim SC, Lee J, Tai ES, Wong TY (2011) Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 54(4):767-775
32. Rhodes DH, Pini M, Castellanos KJ, Montero-Melendez T, Cooper D, et al. (2012) Adipose tissue specific modulation of galectin expression in lean and obese mice: evidence for regulatory function. Obesity (in press)
33. Kiwaki K, Novak CM, Hsu DK, Liu F-T, Levine JA (2007) Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity 15:32-39